Treatment effects and cost-effectiveness of Autonomy-Enhancing Treatment: A person-centered approach to anxiety disorders.
Completed
- Conditions
- fear10002861autonomieproblemenanxiety disorders
- Registration Number
- NL-OMON47059
- Lead Sponsor
- niversiteit van Tilburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 118
Inclusion Criteria
An anxiety disorder according to DSM-IV (excluded obsessive-compulsive disorder and post-traumatic stress disorder)
Exclusion Criteria
Having (a history of) psychosis; addiction; suicidal thoughts or attempts; acute mourning or crisis ; mental retardation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Anxiety symptoms, autonomy-connectedness, general psychopathology, depressive<br /><br>symptoms, self-esteem, quality of life. </p><br>
- Secondary Outcome Measures
Name Time Method <p>We will also estimate cost-effectiveness in terms of quality adjusted life<br /><br>years (QALYs) and direct and indirect costs associated with health care use and<br /><br>work absence/productivity loss.</p><br>